Renalytix AI plc ("RenalytixAI" or the "Company") Notice of results Analyst and Investor presentations NEW YORK , Oct. 16, 2020 /PRNewswire/ -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management
RNS Number : 2682C Renalytix AI PLC 16 October 2020 Renalytix AI plc (" RenalytixAI " or the " Company ") Notice of results Analyst and Investor presentations RenalytixAI To Announce Financial Results for Full Year Ended June 30, 2020 and Provide Corporate Update NEW YORK , October 16,
RNS Number : 9631B Renalytix AI PLC 13 October 2020 Not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or within the United States , Australia , Canada , Hong Kong , Japan , New Zealand , the Republic of South Africa or any other jurisdiction where
RenalytixAI is now currently licensed to provide KidneyIntelX testing services for patients in 49 states NEW YORK, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Renalytix AI, Inc. (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical
RNS Number : 6495Z Renalytix AI PLC 22 September 2020 This announcement contains inside information Renalytix AI plc ("RenalytixAI", the "Company") RenalytixAI Receives California Commercial Laboratory Certification RenalytixAI is now currently licensed to provide KidneyIntelX testing
NEW YORK, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces the
RNS Number : 4123Z Renalytix AI PLC 18 September 2020 This announcement contains inside information Renalytix AI plc ("RenalytixAI", the "Company") RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System NEW YORK , September 18, 2020 - Renalytix AI
RNS Number : 7366X Renalytix AI PLC 02 September 2020 Renalytix AI plc ("RenalytixAI", the "Company") Grant of Purchase Rights under the 2020 Employee Share Purchase Plan and Verici update NEW YORK , September 2, 2020 - Renalytix AI plc ( LSE: RENX) (NASDAQ: RNLX) announces that on 28
NEW YORK, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces that it
RNS Number : 1457X Renalytix AI PLC 26 August 2020 Renalytix AI plc ("RenalytixAI", the "Company") RenalytixAI Files Submission Seeking U.S. FDA Clearance of KidneyIntelX NEW YORK , August 26, 2020 - Renalytix AI plc ( LSE: RENX) (NASDAQ: RNLX), an artificial intelligence -enabled in vitro
